RITA DRAGGS: Open Payments
NPI 1134495088 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 8 companies in 2025. Trend: 2023 $615 · 2024 $4,496 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $71 |
| Iovance Biotherapeutics, Inc. | 3 | $39 |
| JAZZ PHARMACEUTICALS INC. | 2 | $27 |
| Genentech USA, Inc. | 1 | $27 |
| Aveo Pharmaceuticals, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
Products named: TECVAYLI, SCEMBLIX, Amtagvi, KISQALI, Itovebi, RYBREVANT, CARVYKTI, FOTIVDA.
Industry payments across AR — which companies pay providers there.
